Evaluating Antibiotic Stewardship Assisted by Computer in the University Hospital of Nancy (MACABAO)
MACABAO
1 other identifier
observational
100,000
0 countries
N/A
Brief Summary
Antibiotic resistance is one of the most pressing health threats that mankind faces now and in the coming decades. Antibiotic resistance leads to longer hospital stays, higher medical costs and increased mortality. In order to tackle antibiotic resistance, a computerized-decision support system (CDSS) facilitating antibiotic stewardship and an electronic surveillance software (ESS) facilitating infection prevention and control activities will implement in our tertiary care university hospital. The investigators conduct a pragmatic, prospective, single-centre, before-after uncontrolled study with an interrupted time-series analysis 12 months before and 12 months after the introduction of the CDSS for antibiotic stewardship (APSS) and ESS for infection surveillance (ZINC). APSS and ZINC will assist respectively the antibiotic stewardship and the infection prevention and control teams of Nancy University Hospital (France). The investigators will evaluate the impact of the CDSS/ESS on the antibiotic use in adult (≥ 18 years) inpatients (hospitalised ≥ 48h). The primary outcome is the prescription rate by all healthcare professionals from the hospital of all systemic antibiotics expressed in defined daily doses/1 000 patients/month. Concurrently, the investigators will assess the safety of the intervention, its impact on the appropriateness of antibiotic prescriptions and on additional precautions (isolation precautions) as recommended in guidelines, and on bacterial epidemiology (multidrug-resistant bacteria and Clostridioides difficile infections) in the hospital. Finally, the investigators will evaluate the users' satisfaction and the cost of this intervention from the hospital perspective.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2021
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 15, 2021
CompletedFirst Posted
Study publicly available on registry
July 26, 2021
CompletedStudy Start
First participant enrolled
September 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2022
CompletedAugust 26, 2021
July 1, 2021
1 year
July 15, 2021
August 20, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prescription rate of all systemic antibiotics
The prescription rate by all healthcare professionals from the Nancy University Hospital of all systemic antibiotics (J01 code according to the Anatomical Therapeutic Chemical - ATC - 2017 classification) expressed in DDDs/1 000 patients/month.
Calculated monthly during a 12-month before and 12-month after period
Secondary Outcomes (10)
All-cause intra-hospital mortality rate
Calculated monthly during a 12-month before and 12-month after period
Average length of stay
Calculated monthly during a 12-month before and 12-month after period
Incidence of healthcare associated infections
Calculated monthly during a 12-month before and 12-month after period
Use of overall antibiotics and by therapeutic classes
Calculated monthly during a 12-month before and 12-month after period
Proportion of the antibiotic prescriptions compliant with guidelines
Calculated monthly during a 12-month before and 12-month after period
- +5 more secondary outcomes
Study Arms (1)
adult (≥ 18 years) inpatients (hospitalised ≥ 48h)
Interventions
Implementation - in our tertiary care university hospital - of a computerized-decision support system (CDSS) facilitating antibiotic stewardship and of an electronic surveillance software (ESS) facilitating infection prevention and control activities
Eligibility Criteria
Nancy University Hospital (France) is a 1 497-bed tertiary-care hospital including two main geographical sites. In 2017, the point prevalence on one single day of patients treated with antibiotics was 24.4% and the prevalence of HCAI was 7.8% in this University Hospital. And the total antibiotic consumption was 591 DDD/1 000 hospital days. The study includes the inpatients of hospital departments of medicine (intensive care, cardiology, hepato-gastro-enterology, haematology, pneumology, infectious diseases, neurology, …), surgery, long-term care, and rehabilitation care. All inpatients ≥ 18 years and hospitalised ≥ 48h in Nancy University Hospital will be considered in the study.
You may qualify if:
- All inpatients ≥ 18 years and hospitalised ≥ 48h in Nancy University Hospital
You may not qualify if:
- The paediatric and gynaeco-obstetric departments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Baudet A, Agrinier N, Charmillon A, Pulcini C, Lozniewski A, Aissa N, Lizon J, Thilly N, Demore B, Florentin A. Evaluating antibiotic stewardship and healthcare-associated infections surveillance assisted by computer: protocol for an interrupted time series study. BMJ Open. 2022 Apr 5;12(4):e056125. doi: 10.1136/bmjopen-2021-056125.
PMID: 35383069DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Arnaud Florentin, Dr
Université de Lorraine, CHRU-Nancy, APEMAC EA4360, F-54000 Nancy, France
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 15, 2021
First Posted
July 26, 2021
Study Start
September 1, 2021
Primary Completion
September 1, 2022
Study Completion
September 1, 2022
Last Updated
August 26, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share